Cytiva Strategy for Host Cell Protein Control

A critical aspect of therapeutic development and manufacture is host cell protein (HCP) detection, quantitation, and removal from drug substances, to ensure efficacy and prevent immunogenicity.

It is important to mitigate risk by challenging your assay for each new molecule and selecting the most suitable kit.

Cytiva offers a range of solutions to support scientists and developers in creating an effective strategy for HCP control.

Read more about our strategy for HCP control.



Leave a Reply